EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieOpen Access · CC BY 4.0

Driving performance and ocular activity following acute administration of 10 mg methylphenidate: A randomised, double-blind, placebo-controlled study

Blair Aitken iD, Luke A Downey, Serah Rose, Thomas R Arkell, Brook Shiferaw, Amie C Hayley iD

Journal of Psychopharmacology · 2024

DOI: 10.1177/02698811241286715 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Journal of Psychopharmacology, 2024. Verfasst von Blair Aitken und 5 weiteren Autor:innen. Beteiligte Einrichtung: Centre for Mental Health and Brain Sciences, Swinburne University of Technology, Hawthorn, VIC, Australia. Hauptthemen laut MEDLINE: Methylphenidate, Automobile Driving, Central Nervous System Stimulants, Eye Movements. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Methylphenidate is a routinely prescribed treatment for attention-deficit/hyperactivity disorder with misuse potential owing to its perceived performance-enhancing and euphoric properties. Although clinically effective, there is limited understanding of how methylphenidate affects safety-sensitive tasks such as driving when used by healthy individuals.

Aim

Explore the acute effects of 10 mg methylphenidate on driving performance and gaze behaviour.

Methods

Twenty-five fully licensed, healthy adults (mean age = 33.5 ± 7.8 years, 64% male) took part in two 40-min simulated highway drives with simultaneous eye movements monitored using a proprietary automotive-grade driver monitoring system (Seeing Machines). Driving performance was assessed using the standard deviation of lateral position, standard deviation of speed and steering variability. Visual scanning efficiency was determined using ocular metrics, such as fixation duration and rate, gaze transition entropy, and stationary gaze entropy, were assessed to determine visual scanning efficiency.

Results

Methylphenidate significantly improved driving performance by reducing lane weaving and speed variation, particularly in the latter half of the drive. Although a significant reduction in fixation duration was observed, all other ocular metrics remained unchanged.

Conclusions

Methylphenidate mitigates performance decrements typically associated with prolonged and monotonous driving. The absence of pronounced oculomotor effects suggests that a single 10 mg dose of methylphenidate has no deleterious impact on visual scanning behaviour during driving tasks with low-to-moderate cognitive demand. Future research should investigate the effects of methylphenidate under various dosing and driving conditions to better understand its impact. Trial Registration: ACTRN12620000499987.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MethylphenidateAutomobile DrivingCentral Nervous System StimulantsEye MovementsHumansMaleDouble-Blind MethodAdultFemaleYoung AdultPsychomotor Performance

Stichwörter der Autor:innen

Methylphenidatedriving performanceocular monitoringpsychostimulantsroad safety

Substanzen

MethylphenidateCentral Nervous System Stimulants

Autor:innen und Institutionen

  • Centre for Mental Health and Brain Sciences, Swinburne University of Technology, Hawthorn, VIC, Australia.
  • Institute for Breathing and Sleep, Austin Health, Heidelberg, VIC, Australia.
  • Seeing Machines, Fyshwick, ACT, Australia.

ORCID-Profile: Blair Aitken, Amie C Hayley

Zitieren

APA

Aitken, B., Downey, L. A., Rose, S., Arkell, T. R., Shiferaw, B., & Hayley, A. C. (2024). Driving performance and ocular activity following acute administration of 10 mg methylphenidate: A randomised, double-blind, placebo-controlled study. Journal of Psychopharmacology. https://doi.org/10.1177/02698811241286715

Vancouver

Aitken B, Downey LA, Rose S, Arkell TR, Shiferaw B, Hayley AC. Driving performance and ocular activity following acute administration of 10 mg methylphenidate: A randomised, double-blind, placebo-controlled study. Journal of Psychopharmacology. 2024. doi:10.1177/02698811241286715

BibTeX
@article{Aitken2024,
  author = {Aitken, Blair and Downey, Luke A and Rose, Serah and Arkell, Thomas R and Shiferaw, Brook and Hayley, Amie C},
  title = {Driving performance and ocular activity following acute administration of 10 mg methylphenidate: A randomised, double-blind, placebo-controlled study},
  journal = {Journal of Psychopharmacology},
  year = {2024},
  doi = {10.1177/02698811241286715}
}
Kostenlos starten →